A high-performance liquid chromatography assay for yohimbine HCl analysis.
The analysis used yohimbine HCl solution prepared from commercially available yohimbine HCl powder. Stability-indicating high-performance liquid chromatographic (HPLC) assay procedures were established and utilized to analyze the concentration of the drug. The method proved to be a simple model since it does not contain a buffer system. The mobile phase used, a methanol:water 70:30 ratio, was similar to that suggested by the manufacturer for the storage of the column. Therefore, the solvent system saves analytical processing time since it does not require a change in the mobile phase before and after the analysis. The analytical method has been shown to be stability indicating. The assay method showed a retention time for yohimbine of 4.2 min; for caffeine, the internal standard, it was 2.3 min. The standard deviation and the coefficient of variation were under acceptable limits of 2% and were specifically 1.51% and 1.35% for within-day and between-day samples, respectively. The results showed that the degradation products obtained from stressing yohimbine HCl by heat and extremes in pH did not interfere with the yohimbine HCl peak, although the internal standard, caffeine, did show some interference due to having a retention time similar to the degradation products.
Mittal
S
S
College of Pharmacy, University of Toledo, OH 43606, USA.
Alexander
K S
KS
Dollimore
D
D
D000317:Adrenergic alpha-Antagonists / Q000032:analysis*; D002110:Caffeine / Q000032:analysis; D002138:Calibration; D000697:Central Nervous System Stimulants / Q000032:analysis; D006358:Hot Temperature; D006851:Hydrochloric Acid / Q000032:analysis; D006863:Hydrogen-Ion Concentration; D012680:Sensitivity and Specificity; D012997:Solvents; D015016:Yohimbine / Q000032:analysis*
D000317:Adrenergic alpha-Antagonists; D000697:Central Nervous System Stimulants; D012997:Solvents; D015016:Yohimbine; D002110:Caffeine; D006851:Hydrochloric Acid